Abstract
This research compares the methodological quality and transferability assessments of six checklists using ten economic evaluations of genetic-guided pharmacotherapy for venous thromboembolism and considers implications for systematic reviews and decision making.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have